Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

N/ACompletedNCT01552395

Ferring Pharmaceuticals4,136 enrolled

Overview

A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice

Study Type

OBSERVATIONAL

Enrollment

4,136

Conditions

Nocturia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * nocturia Exclusion Criteria: * habitual or psychogenic polydipsia, * known or suspected cardiac insufficiency * other conditions requiring treatment with diuretics * moderate and severe renal insufficiency * known hyponatremia * syndrome of inappropriate ADH secretion

Locations (68)

Outcomes

Primary Outcomes

Number of patients with adverse events

Time frame: 24 months

Secondary Outcomes

Number of changes in dosage regime

Time frame: 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Nemocnice Rudolfa a Stefanie (there may be other sites in this country)

Benešov, Czechia

Soukromá ambulance, Benešov

Benešov, Czechia

Soukromá ambulance Beroun

Beroun, Czechia

Slezská urologie

Bohunín, Czechia

URIONTEGRITAS soukromá ambulance

Brno, Czechia

Uro - clinic

Brno, Czechia

Urocentrum Brno

Brno, Czechia

Úrazová nemocnice Brno

Brno, Czechia

Soukromá ambalance

Citonice, Czechia

Domažlická Nemocnice

Domažlice, Czechia

...and 58 more locations

NCT01552395 - A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia | Crick | Crick